CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
4.670
-0.150 (-3.11%)
At close: Nov 17, 2026, 4:00 PM EST
4.690
+0.020 (0.43%)
After-hours: Nov 17, 2026, 7:42 PM EST
CorMedix Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, CorMedix stock has a consensus rating of "Buy" and an average price target of $13.8. The average 1-year stock price forecast is 195.50% higher than the current stock price, while the lowest is $12 (+156.96%) and the highest is $17 (+264.03%).
Price Target: $13.8 (+195.50%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for CorMedix stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Reiterates $15 → $13 | Buy | Reiterates | $15 → $13 | +178.37% | Nov 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $13 | Buy | Reiterates | $13 | +178.37% | Nov 13, 2026 |
| Needham | Needham | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +199.79% | Nov 10, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $15 → $14 | Buy | Maintains | $15 → $14 | +199.79% | Nov 10, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $16 | Buy | Reiterates | $16 | +242.61% | Oct 20, 2026 |
Financial Forecast
Revenue This Year
336.80M
from 311.71M
Increased by 8.05%
Revenue Next Year
319.89M
from 336.80M
Decreased by -5.02%
EPS This Year
0.97
from 2.15
Decreased by -54.80%
EPS Next Year
0.35
from 0.97
Decreased by -63.92%
EPS and Forward PE are based on non-GAAP adjusted numbers.